+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Mens Health Diagnostics Market by Product, Type or Indication, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5533359
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Mens Health Diagnostics Market grew from USD 13.17 billion in 2023 to USD 14.59 billion in 2024. It is expected to continue growing at a CAGR of 11.31%, reaching USD 27.89 billion by 2030.

The men's health diagnostics market encompasses a wide array of tests, procedures, and tools designed to monitor and diagnose male-specific health issues, such as prostate cancer, low testosterone levels, and erectile dysfunction. Necessity for these diagnostics stems from increasing awareness of men's health issues and the growing prevalence of chronic diseases among men. The application predominantly involves blood tests, imaging, biopsies, and genetic screenings. End-use segments comprise hospitals, clinics, diagnostic centers, and home care settings. Key growth influencers include the rising aging male population, developments in diagnostic technologies, and increasing male awareness about specific health conditions. Opportunities are abundant in emerging markets with untapped potential and a growing inclination toward preventive healthcare. Collaborations between tech firms and healthcare providers can further fuel innovation in personalized diagnostics. Challenges include societal stigma surrounding men’s health issues, leading to underdiagnosis. High diagnostic costs and limited access to healthcare in developing nations pose additional concerns. Innovation can be best directed towards developing non-invasive and at-home diagnostic solutions, integrating artificial intelligence for precise predictions, and advancing telehealth services for better patient engagement. Furthermore, gene-editing technologies and personalized medicine offer fertile ground for research and development. Market insights reveal a transition towards personalized, technology-driven solutions, creating opportunities for companies adept in leveraging AI and data analytics to develop innovative diagnostic solutions. However, companies must strategize to overcome barriers like regulatory hurdles and data privacy concerns. Overall, the focus should be on raising awareness, reducing costs, enhancing accessibility, and addressing ethical concerns. By addressing these areas, businesses can significantly contribute to the market's growth while fostering a healthier male population globally.

Understanding Market Dynamics in the Mens Health Diagnostics Market

The Mens Health Diagnostics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Unhealthy eating habits and growing prevalence of smoking population
    • Increased incidence of lifestyle disease
    • Rise in number of diagnostic centers all over the globe
  • Market Restraints
    • Uneven distribution of medical services
    • Limited insurance coverage and regulatory compliance
  • Market Opportunities
    • Favorable government initiatives to strengthen healthcare system
    • Integration of innovative technologies such as IoT and AI in diagnostic
  • Market Challenges
    • Shortage of skilled and experienced workforce

Exploring Porter’s Five Forces for the Mens Health Diagnostics Market

Porter’s Five Forces framework further strengthens the insights of the Mens Health Diagnostics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Mens Health Diagnostics Market

External macro-environmental factors deeply influence the performance of the Mens Health Diagnostics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Mens Health Diagnostics Market

The Mens Health Diagnostics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Mens Health Diagnostics Market

The Mens Health Diagnostics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Mens Health Diagnostics Market

The Mens Health Diagnostics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mens Health Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Access Pharmaceuticals, Inc., ADVANZ PHARMA Corp Limited, Beckman Coulter, Inc., Bruker Corporation, Cardinal Health Inc., Ecotown Diagnostics Pvt. Ltd., F. Hoffmann-La Roche Ltd., Future Diagnostics Solutions B.V., Medical Diagnosis, Neuberg Diagnostics, Nuance Communications, Inc., Pathnostics, PERSOWN, INC., Quest Diagnostics Incorporated, and SEKISUI DIAGNOSTICS, LLC.

Market Segmentation & Coverage

This research report categorizes the Mens Health Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Blood Test
    • Electrocardiogram
    • MRI of the Prostate
    • Testosterone Levels Test
    • Ultrasound Test
    • Ultrasound-Guided Prostate Biopsy
    • Urethrogram
    • Urine Tests
    • X-Ray
  • Type or Indication
    • Colorectal Cancer
    • Erectile Dysfunction
    • Prostate Cancer
    • Testicular cancer
  • End-user
    • Diagnostic Laboratories
    • Hospitals & Ambulatory Surgery Center
    • Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Unhealthy eating habits and growing prevalence of smoking population
5.1.1.2. Increased incidence of lifestyle disease
5.1.1.3. Rise in number of diagnostic centers all over the globe
5.1.2. Restraints
5.1.2.1. Uneven distribution of medical services
5.1.2.2. Limited insurance coverage and regulatory compliance
5.1.3. Opportunities
5.1.3.1. Favorable government initiatives to strengthen healthcare system
5.1.3.2. Integration of innovative technologies such as IoT and AI in diagnostic
5.1.4. Challenges
5.1.4.1. Shortage of skilled and experienced workforce
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Mens Health Diagnostics Market, by Product
6.1. Introduction
6.2. Blood Test
6.3. Electrocardiogram
6.4. MRI of the Prostate
6.5. Testosterone Levels Test
6.6. Ultrasound Test
6.7. Ultrasound-Guided Prostate Biopsy
6.8. Urethrogram
6.9. Urine Tests
6.10. X-Ray
7. Mens Health Diagnostics Market, by Type or Indication
7.1. Introduction
7.2. Colorectal Cancer
7.3. Erectile Dysfunction
7.4. Prostate Cancer
7.5. Testicular cancer
8. Mens Health Diagnostics Market, by End-user
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Hospitals & Ambulatory Surgery Center
8.4. Research & Academic Institutes
9. Americas Mens Health Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Mens Health Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Mens Health Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. MENS HEALTH DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. MENS HEALTH DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. MENS HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. MENS HEALTH DIAGNOSTICS MARKET DYNAMICS
TABLE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY MRI OF THE PROSTATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTOSTERONE LEVELS TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND-GUIDED PROSTATE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URETHROGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY ERECTILE DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TESTICULAR CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & AMBULATORY SURGERY CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 41. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 55. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 58. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 64. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 67. MALAYSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 70. PHILIPPINES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 73. SINGAPORE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 76. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 79. TAIWAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 82. THAILAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 85. VIETNAM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 92. DENMARK MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 95. EGYPT MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 98. FINLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 101. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 104. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 107. ISRAEL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 110. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 116. NIGERIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 119. NORWAY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 122. POLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 125. QATAR MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 131. SAUDI ARABIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 134. SOUTH AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 137. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 140. SWEDEN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 143. SWITZERLAND MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 146. TURKEY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE OR INDICATION, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 154. MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Mens Health Diagnostics Market, which are profiled in this report, include:
  • Access Pharmaceuticals, Inc.
  • ADVANZ PHARMA Corp Limited
  • Beckman Coulter, Inc.
  • Bruker Corporation
  • Cardinal Health Inc.
  • Ecotown Diagnostics Pvt. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Future Diagnostics Solutions B.V.
  • Medical Diagnosis
  • Neuberg Diagnostics
  • Nuance Communications, Inc.
  • Pathnostics
  • PERSOWN, INC.
  • Quest Diagnostics Incorporated
  • SEKISUI DIAGNOSTICS, LLC

Methodology

Loading
LOADING...

Table Information